IMMATURE PLATELET FRACTION TEST, in Visit Clinic

The immature platelet fraction (IPF) test is a blood test that measures the percentage and absolute number of young, RNA-containing platelets recently released from the bone marrow. Performed on automated hematology analyzers, IPF helps distinguish thrombocytopenia caused by increased peripheral destruction or consumption (high IPF) from decreased marrow production (low IPF), and monitors platelet recovery after treatment or stimulation.

A high Immature Platelet Fraction (IPF) means the bone marrow is actively producing and releasing young platelets. It typically indicates peripheral platelet loss or destruction (for example immune-mediated destruction, bleeding, or consumption from infection) or marrow recovery after suppression. High IPF suggests the marrow can respond, helping distinguish peripheral causes from bone marrow failure and guiding diagnosis and treatment decisions.

The immature platelet fraction (IPF) is normally about 1–7% of circulating platelets, though exact reference ranges vary by laboratory and analyzer. A high IPF suggests increased platelet production (for example after platelet destruction), while a low IPF with thrombocytopenia points to reduced bone marrow production. Always interpret IPF alongside the local lab’s reference interval and clinical context.

Immature platelet fraction (IPF) measures young, newly released platelets in blood. In dengue, thrombocytopenia often accompanies a raised IPF, indicating increased bone marrow platelet production compensating for peripheral destruction or consumption. A low or falling IPF suggests marrow suppression and higher bleeding risk. Serial IPF helps monitor recovery and guide management during acute dengue.

Yes — an elevated immature platelet fraction (IPF) can indicate increased platelet production that often accompanies peripheral platelet destruction or consumption, and it is frequently seen during infections, especially sepsis, as the marrow responds. High IPF helps distinguish increased turnover from reduced production, but it’s not specific; clinical correlation and other tests are required to determine whether infection is the cause.

ITP (immune thrombocytopenia) is an autoimmune disorder causing isolated low platelets and bleeding; bone marrow shows normal or increased megakaryocytes. Leukemia is a malignant cancer of blood-forming cells causing abnormal white cell proliferation, often with anemia, infections, and low platelets. Diagnosis uses blood counts, peripheral smear and bone marrow biopsy; treatments differ: ITP uses immunosuppression/IVIG/splenectomy, whereas leukemia requires chemotherapy/targeted therapy.